Morgan Stanley’s Lucid Diagnostics LUCD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537K | Buy |
466,630
+355,040
| +318% | +$408K | ﹤0.01% | 5433 |
|
|
2025
Q1 | $166K | Buy |
111,590
+56,996
| +104% | +$84.9K | ﹤0.01% | 5812 |
|
|
2024
Q4 | $44.7K | Buy |
54,594
+54,200
| +13,756% | +$44.4K | ﹤0.01% | 6319 |
|
|
2024
Q3 | $321 | Sell |
394
-560
| -59% | -$456 | ﹤0.01% | 7346 |
|
|
2024
Q2 | $782 | Sell |
954
-22
| -2% | -$18 | ﹤0.01% | 7183 |
|
|
2024
Q1 | $790 | Buy |
976
+576
| +144% | +$466 | ﹤0.01% | 7197 |
|
|
2023
Q4 | $564 | Buy |
400
+200
| +100% | +$282 | ﹤0.01% | 7269 |
|
|
2023
Q3 | $234 | Hold |
200
| – | – | ﹤0.01% | 7373 |
|
|
2023
Q2 | $278 | Sell |
200
-600
| -75% | -$834 | ﹤0.01% | 7425 |
|
|
2023
Q1 | $1.12K | Sell |
800
-93
| -10% | -$130 | ﹤0.01% | 7337 |
|
|
2022
Q4 | $1.21K | Sell |
893
-18,361
| -95% | -$25K | ﹤0.01% | 7443 |
|
|
2022
Q3 | $30K | Sell |
19,254
-39,092
| -67% | -$60.9K | ﹤0.01% | 6621 |
|
|
2022
Q2 | $131K | Buy |
58,346
+49,117
| +532% | +$110K | ﹤0.01% | 6129 |
|
|
2022
Q1 | $31K | Sell |
9,229
-12,533
| -58% | -$42.1K | ﹤0.01% | 6937 |
|
|
2021
Q4 | $116K | Buy |
+21,762
| New | +$116K | ﹤0.01% | 6352 |
|